Come up with a name for your new list and we'll add to it:
Ambrx raised a round of funding on July 07, 2006. Investors include
Scottish Widows Investment Partnership.
Ambrx is a clinical-stage biotechnology company focused on discovering and developing first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates. The company's proprietary…